This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas

NCT01279772 · clinicaltrials.gov ↗

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped due to slow accrual (only 1 patient entered)

Conditions

Diffuse Large B-Cell Lymphoma of the Breast

Sponsor

International Extranodal Lymphoma Study Group (IELSG)